Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

THE COST OF TREATMENT FOR PEDIATRIC TUBERCULOSIS PATIENTS: A CROSS-SECTIONAL STUDY

Jurnal Administrasi Kesehatan Indonesia · Vol. 13 No. 2 (2025) · hlm. 142–151

DOI
10.20473/jaki.v13i2.2025.142-151
ISSN
2540-9301, 2303-3592
Terbit
2025-12-04
Penerbit
Universitas Airlangga
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

Background: Tuberculosis (TB) is a leading global communicable disease. Pediatric tuberculosis, in particular, is prevalent among the population aged 0-14 years and necessitates a treatment duration of at least six months. Aims: This study aims to assess the total treatment cost of pediatric tuberculosis patients and determine the factors associated with the total cost. Methods: A cross-sectional design was employed to collect the retrospective data at a public hospital and PHC in the province-level Special Region of Yogyakarta, Indonesia. Treatment costs are categorized into the following: laboratory costs, professional costs, drug costs, medical and non-medical support costs, and miscellaneous costs. The collected data underwent both descriptive and statistical analysis using regression methods, namely logistic and probit regressions. Results: The analysis revealed that most patients were between 0 and 2 years old and most of them are school-age, with an average treatment cost of USD 62.80 per patient. The study identified laboratory costs (RR 0.198; 95% CI 0.083-0.314), professional costs (RR 9.402; 95% CI 4.108-14.698), drug costs (RR 5.269; 95% CI 2.326-8.212), and medical support costs (RR 0.223;95% CI 0.064-0.382) as the primary contributors to the total cost. Conclusion: The point of this study is that effective treatment is possible with proper financial support. To achieve a successful outcome in treating pediatric tuberculosis, it is imperative to establish an advocacy and collaboration effort to enhance the primary health services. This cooperative effort should prioritize convenient access to treatment and enhancing active case finding. Keywords: cost of illness, cost of treatment, pediatric tuberculosis

Kata kunci

Jaringan kolaborasi para penulis

36 penulis · 128 tautan kepenulisan bersama · 76 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • National Research and Innovation Agency
  • Universitas Airlangga
  • Universitas Jember
  • Universitas Muhammadiyah Semarang
  • Lambung Mangkurat University
  • Kementerian Kesehatan Republik Indonesia
  • Universitas Sari Mulia
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Debri Rizki FaisalNational Research and Innovation Agency2
Syarifah NurainiNational Research and Innovation Agency2
Indah PawitaningtyasNational Research and Innovation Agency2
Linta Meyla PutriUniversitas Airlangga2
RistiyantoNational Research and Innovation Agency2
Carine MilcentParis School of Economics2
Isnawati -Poltekkes Kemenkes Banjarmasin1
Nurul HidayahUniversitas Sari Mulia1
Triwibowo Ambar GarjitoNational Research and Innovation Agency1
Muhammad Rasyid RidhaLambung Mangkurat University1
Ririh YudhastutiUniversitas Airlangga1
Liestiana IndriyatiKementerian Kesehatan Republik Indonesia1
Babucarr JasseyMinistry of Health and Social Welfare1
JuhairiyahNational Research and Innovation Agency1
Muhammad Choirul HidajatNational Research and Innovation Agency1
Dewi Retno SuminarUniversitas Airlangga1
Thinni Nurul RochmahUniversitas Airlangga1
Ulfia Hazna SafiraUniversitas Airlangga1
Risky Kusuma HartonoUniversitas Indonesia Maju1
Asri Hikmatuz ZahrohAfiliasi tidak diketahui1
Ratna Dwi WulandariUniversitas Airlangga1
Agung Dwi LaksonoNational Research and Innovation Agency1
Taufiq HidayatNational Research and Innovation Agency1
Diyan Ermawan EffendiNational Research and Innovation Agency1
Leny LatifahNational Research and Innovation Agency1
Diah YunitawatiNational Research and Innovation Agency1
Dennis B. BatanganAteneo de Manila University1
Irma PrasetyowatiUniversitas Jember1
Zulfa MazidaUniversitas Jember1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://e-journal.unair.ac.id/JAKI/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 9 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">THE COST OF TREATMENT FOR PEDIATRIC TUBERCULOSIS PATIENTS: A CROSS-SECTIONAL STUDY</dc:title>
	<dc:creator>Lestyoningrum, Sinta Dewi</dc:creator>
	<dc:creator>Noveyani, Adistha Eka</dc:creator>
	<dc:creator>Putro, Wahyu Gito</dc:creator>
	<dc:creator>Faisal, Debri Riski</dc:creator>
	<dc:creator>Purwatiningsih, Yuni</dc:creator>
	<dc:creator>Mikrajab, Muhammad Agus</dc:creator>
	<dc:creator>Nugraheni, Wahyu Pudji</dc:creator>
	<dc:subject xml:lang="en-US">cost of illness</dc:subject>
	<dc:subject xml:lang="en-US">cost of treatment</dc:subject>
	<dc:subject xml:lang="en-US">pediatric tuberculosis</dc:subject>
	<dc:subject xml:lang="en-US">health administration and policy</dc:subject>
	<dc:subject xml:lang="en-US">health management</dc:subject>
	<dc:description xml:lang="en-US">Background: Tuberculosis (TB) is a leading global communicable disease. Pediatric tuberculosis, in particular, is prevalent among the population aged 0-14 years and necessitates a treatment duration of at least six months.
Aims: This study aims to assess the total treatment cost of pediatric tuberculosis patients and determine the factors associated with the total cost.
Methods: A cross-sectional design was employed to collect the retrospective data at a public hospital and PHC in the province-level Special Region of Yogyakarta, Indonesia. Treatment costs are categorized into the following: laboratory costs, professional costs, drug costs, medical and non-medical support costs, and miscellaneous costs. The collected data underwent both descriptive and statistical analysis using regression methods, namely logistic and probit regressions.
Results: The analysis revealed that most patients were between 0 and 2 years old and most of them are school-age, with an average treatment cost of USD 62.80 per patient. The study identified laboratory costs (RR 0.198; 95% CI 0.083-0.314), professional costs (RR 9.402; 95% CI 4.108-14.698), drug costs (RR 5.269; 95% CI 2.326-8.212), and medical support costs (RR 0.223;95% CI 0.064-0.382) as the primary contributors to the total cost.
Conclusion: The point of this study is that effective treatment is possible with proper financial support. To achieve a successful outcome in treating pediatric tuberculosis, it is imperative to establish an advocacy and collaboration effort to enhance the primary health services. This cooperative effort should prioritize convenient access to treatment and enhancing active case finding.
Keywords: cost of illness, cost of treatment, pediatric tuberculosis</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Airlangga</dc:publisher>
	<dc:date>2025-12-04</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-Reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>text/xml</dc:format>
	<dc:identifier>https://e-journal.unair.ac.id/JAKI/article/view/69113</dc:identifier>
	<dc:identifier>10.20473/jaki.v13i2.2025.142-151</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Health Administration (Jurnal Administrasi Kesehatan Indonesia); Vol. 13 No. 2 (2025): December; 142-151</dc:source>
	<dc:source>2540-9301</dc:source>
	<dc:source>2303-3592</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://e-journal.unair.ac.id/JAKI/article/view/69113/35223</dc:relation>
	<dc:relation>https://e-journal.unair.ac.id/JAKI/article/view/69113/35715</dc:relation>
	<dc:coverage xml:lang="en-US">Yogyakarta</dc:coverage>
	<dc:rights xml:lang="en-US">Copyright (c) 2025 Sinta Dewi Lestyoningrum, Adistha Eka Noveyani, Wahyu Gito Putro, Debri Riski Faisal, Yuni Purwatiningsih, Muhammad Agus Mikrajab, Wahyu Pudji Nugraheni</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>